Skip to main content


News Filter

News Articles List

90+ presentations underscore Sarah Cannon’s expertise in drug development

Leading Provider of Cloud-based Genomics Technology Joins HCA's Global Cancer Institute to Grow Reach in Precision Medicine for People Facing...

Molecular Information-based Collaboration Focuses on Integrating Comprehensive Genomic Profiling into Clinical Trials to Enable Patient Access...

$12 million research project aimed at demonstrating the quality assurance of oncology nurse navigation to improve care and outcomes

Joint clinical development will study the combination of two checkpoint inhibitors from Boehringer Ingelheim's growing immune-oncology pipeline

Ticket On-Sale Begins August 5 at 10 a.m. at; The Sarah Cannon Tour aims to connect people facing blood cancer with community...

Sarah Cannon is pleased to announce the promotion of Erika P. Hamilton, MD, to director, breast and gynecologic cancer research program.

News Related Content